Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0501 for Cough in COPD
NCT02233686Phase 2Completed
- Sponsor
- Xention Ltd.
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XEN-D0501 in chronic obstructive pulmonary disease (COPD), sponsored by Xention Ltd.. Started Feb 2014; status: completed.
02
Drugs
XEN-D0501
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02233686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233686.